Your browser doesn't support javascript.
loading
COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases.
Martin, P; Tsourti, Z; Ribeiro, J; Castelo-Branco, L; de Azambuja, E; Gennatas, S; Rogado, J; Sekacheva, M; Susnjar, S; Viñal, D; Lee, R; Khallaf, S; Dimopoulou, G; Pradervand, S; Whisenant, J; Choueiri, T K; Arnold, D; Harrington, K; Punie, K; Oliveira, J; Michielin, O; Dafni, U; Peters, S; Pentheroudakis, G; Romano, E.
Affiliation
  • Martin P; Department of Oncology, Institut Curie, Paris, France.
  • Tsourti Z; Frontier Science Foundation-Hellas, Athens, Greece.
  • Ribeiro J; Gustave Roussy, Department of Cancer Medicine, Villejuif, France.
  • Castelo-Branco L; NOVA National School of Public Health, NOVA University, Lisbon, Portugal; Scientific and Medical Division, ESMO (European Society for Medical Oncology), Lugano, Switzerland.
  • de Azambuja E; Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B), Brussels, Belgium.
  • Gennatas S; Medical Oncology Department, The Royal Marsden Hospital - NHS Foundation Trust, London, UK.
  • Rogado J; Medical Oncology Department, Hospital Universitario Infanta Leonor, Madrid, Spain.
  • Sekacheva M; World-Class Research Center 'Digital Biodesign and Personalized Healthcare', Sechenov First Moscow State Medical University, Moscow, Russia.
  • Susnjar S; Department of Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.
  • Viñal D; Medical Oncology Department, Hospital Universitario La Paz, Madrid, Spain.
  • Lee R; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester; Medical Oncology Department, The Christie NHS Foundation Trust, Manchester, UK.
  • Khallaf S; Medical Oncology Department, South Egypt Cancer Institute (SECI), Assiut University, Assiut, Egypt.
  • Dimopoulou G; Frontier Science Foundation-Hellas, Athens, Greece.
  • Pradervand S; Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Whisenant J; Vanderbilt University Medical Center, Nashville.
  • Choueiri TK; The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston; Harvard Medical School, Boston, USA.
  • Arnold D; Asklepios Tumorzentrum Hamburg, AK Altona, Department of Oncology, Haematology and Palliative Care, Hamburg, Germany.
  • Harrington K; Division of Radiotherapy and Imaging, The Royal Marsden/The Institute of Cancer Research NIHR Biomedical Research Centre, London, UK.
  • Punie K; Department of General Medical Oncology and Multidisciplinary Breast Centre, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Oliveira J; Department of Medicine, Instituto Português de Oncologia, Porto, Portugal.
  • Michielin O; Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Dafni U; Laboratory of Biostatistics, School of Health Sciences, National and Kapodistrian University of Athens, Athens Frontier Science Foundation-Hellas, Athens, Greece.
  • Peters S; Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Pentheroudakis G; Scientific and Medical Division, ESMO (European Society for Medical Oncology), Lugano, Switzerland.
  • Romano E; Department of Oncology, Institut Curie, Paris, France. Electronic address: Emanuela.Romano@curie.fr.
ESMO Open ; 8(3): 101566, 2023 Jun.
Article in En | MEDLINE | ID: mdl-37285719

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: ESMO Open Year: 2023 Document type: Article Affiliation country: Francia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: ESMO Open Year: 2023 Document type: Article Affiliation country: Francia